Richard R. DeLuca, EVP&Pres, Merck Animal Heallth at Merck, sold MRK on Aug 6, 2026
Data as of Oct 16
▼ SELL$39.3K300 shares at $131.02Richard R. DeLuca EVP&Pres, Merck Animal HeallthMRK Merck & Co., Inc.
- Traded
- Aug 6, 2026
- Disclosed
- Aug 10, 2026
- Filed
- 4 days after the trade
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
MRK since disclosure
+11.5%
after the sale
Similar stocks (XLV) since disclosure
+4.9%
XLV — its sector index fund
Change in closing price from Aug 10, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.
Other trades in the same filing
- ▼ SELLRichard R. DeLuca EVP&Pres, Merck Animal HeallthMRK Merck & Co., Inc.$644Kdisclosed Aug 10 · filed 4 days after the trade
- ▼ SELLRichard R. DeLuca EVP&Pres, Merck Animal HeallthMRK Merck & Co., Inc.$105Kdisclosed Aug 10 · filed 4 days after the trade